Oncology

All Articles in the Category ‘Oncology’

Exploring a New Path Forward for Pediatric Cancer Care and Research

Seattle Children’s is working in partnership with Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance (SCCA) to explore restructuring our longtime relationship to accelerate our shared mission of advancing diagnosis, treatment and pioneering of cures for cancer and other diseases. If the proposed restructure is finalized and approved, it will establish an adult-focused oncology program and a separate pediatric oncology program that operate collaboratively and will integrate the innovative cancer research from Fred Hutch, UW Medicine and Seattle Children’s.

Read full post »

Cancer and Blood Disorders Program Poised for Accelerated Growth With Addition of Dr. Mignon Loh

Dr. Mignon Loh – New Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy Division Chief and BTCCCR Center Director

Message from Dr. Leslie Walker-Harding, chair, University of Washington School of Medicine Department of Pediatrics; senior vice president and chief academic officer, Seattle Children’s

I am thrilled to announce that on Dec. 1 Dr. Mignon Loh will join the University of Washington (UW) School of Medicine’s Department of Pediatrics as division chief of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy. In this role, she will provide clinical leadership at Seattle Children’s Cancer and Blood Disorders Center and research leadership as center director of the Ben Towne Center for Childhood Cancer Research (BTCCCR) at Seattle Children’s Research Institute. Loh will also serve as professor in the Department of Pediatrics at the UW School of Medicine, as well as head of the Section of Pediatric Oncology at Fred Hutchinson Cancer Research Center (Fred Hutch). Read full post »

CME Events: October 2020 – Hematology and Cancer Updates; Workup and Management of Pediatric Urologic Conditions

Work-Up and Management of Pediatric Urologic Conditions

Wednesday, Oct. 28, 5:30 to 6:45 p.m. MDT (Webex)

New Thoughts and Algorithms for Workup and Management of Pediatric Urologic Conditions

Category II CME credit

Speakers: Drs. Paul Merguerian, MD, MS, and Mark Cain, and Carlyn Doyle, NP

RSVP by Oct. 27 to Kenton.mcallister@seattlechildrens.org or mswanson@communitymed.org. Read full post »

Clinical Trial: Cancer Drug Shows Promise of Minimizing Heart Damage

For many patients undergoing treatment for cancer, there is not just the immediate worry about beating the disease but also the longer-term prospect of surviving the harsh side effects of the drugs that saved them. Almost five years ago, On the Pulse featured a clinical trial led by Dr. Todd Cooper to study the safety and efficacy of a cancer drug called CPX-351. Cooper and his team wanted to find out if CPX-351 could help young cancer patients survive their disease without the long-term cardiac damage so often caused by other drugs. Read full post »

September is Childhood Cancer Awareness Month

In honor of Childhood Cancer Awareness Month, we would like to share with you the following information on T-Cell Immunotherapy at Seattle Children’s. For more information visit www.seattlechildrens.org/t-cell-trials

I Was Not Ready to Die: How Seattle Children’s Immunotherapy Saved My Life

Seattle Children’s doctors and researchers are leading efforts to better treat cancer in children, adolescents and young adults by boosting the immune system with T-cell immunotherapy. Patients who cannot be cured with standard therapies are benefiting from clinical trials developed at the Ben Towne Center for Childhood Cancer Research, and supported by the Strong Against Cancer initiative. 

One of these patients is Aaron. When he feared he might be out of treatment options, Aaron found hope at Seattle Children’s. 

Read Aaron’s story on Seattle Children’s blog On The Pulse.
Read full post »